25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Evotec SE
Buy, Hold or Sell?

Let's analyze Evotec together

I guess you are interested in Evotec SE. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Evotec SE. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Evotec SE

I send you an email if I find something interesting about Evotec SE.

1. Quick Overview

1.1. Quick analysis of Evotec (30 sec.)










1.2. What can you expect buying and holding a share of Evotec? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€5.70
Expected worth in 1 year
€4.78
How sure are you?
48.4%

+ What do you gain per year?

Total Gains per Share
€-0.92
Return On Investment
-9.2%

For what price can you sell your share?

Current Price per Share
€9.95
Expected price per share
€6.62 - €12.88
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Evotec (5 min.)




Live pricePrice per Share (EOD)
€9.95
Intrinsic Value Per Share
€-28.49 - €-34.08
Total Value Per Share
€-22.79 - €-28.38

2.2. Growth of Evotec (5 min.)




Is Evotec growing?

Current yearPrevious yearGrowGrow %
How rich?$1b$1.2b-$104.3m-9.1%

How much money is Evotec making?

Current yearPrevious yearGrowGrow %
Making money-$44.7m-$27m-$17.6m-39.5%
Net Profit Margin-22.5%-13.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Evotec (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Evotec?

Welcome investor! Evotec's management wants to use your money to grow the business. In return you get a share of Evotec.

First you should know what it really means to hold a share of Evotec. And how you can make/lose money.

Speculation

The Price per Share of Evotec is €9.95. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Evotec.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Evotec, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €5.70. Based on the TTM, the Book Value Change Per Share is €-0.23 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.14 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Evotec.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.56-5.6%-0.25-2.5%-0.13-1.3%-0.03-0.4%-0.01-0.1%
Usd Book Value Change Per Share-0.56-5.6%-0.24-2.4%-0.15-1.5%0.171.7%0.191.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.56-5.6%-0.24-2.4%-0.15-1.5%0.171.7%0.191.9%
Usd Price Per Share9.31-16.64-19.24-25.22-22.31-
Price to Earnings Ratio-4.15--28.87--46.41-120.35-112.51-
Price-to-Total Gains Ratio-16.60--122.57--139.54--108.56-61.85-
Price to Book Ratio1.56-2.55-2.73-5.36-11.68-
Price-to-Total Gains Ratio-16.60--122.57--139.54--108.56-61.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share10.426605
Number of shares95
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.240.17
Usd Total Gains Per Share-0.240.17
Gains per Quarter (95 shares)-22.8216.04
Gains per Year (95 shares)-91.2964.18
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-91-10106454
20-183-1920128118
30-274-2830193182
40-365-3740257246
50-456-4650321310
60-548-5560385374
70-639-6470449438
80-730-7380513502
90-822-8290578566
100-913-9200642630

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%7.013.00.035.0%17.014.00.054.8%17.014.00.054.8%
Book Value Change Per Share0.04.00.00.0%2.09.01.016.7%7.012.01.035.0%15.015.01.048.4%15.015.01.048.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.031.00.0%0.00.031.00.0%
Total Gains per Share0.04.00.00.0%2.09.01.016.7%7.012.01.035.0%15.015.01.048.4%15.015.01.048.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Evotec SE compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.535-0.229-57%-0.143-73%0.161-432%0.184-391%
Book Value Per Share--5.6976.165-8%6.726-15%5.277+8%3.978+43%
Current Ratio--1.8341.952-6%2.124-14%2.514-27%2.351-22%
Debt To Asset Ratio--0.4940.497-1%0.474+4%0.499-1%0.480+3%
Debt To Equity Ratio--0.9760.990-1%0.901+8%1.028-5%0.970+1%
Dividend Per Share----0%-0%-0%-0%
Eps---0.535-0.240-55%-0.128-76%-0.033-94%-0.008-99%
Free Cash Flow Per Share---0.507-0.348-31%-0.348-31%-0.099-80%-0.047-91%
Free Cash Flow To Equity Per Share---1.178-0.438-63%-0.332-72%0.050-2447%0.124-1052%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---34.080--------
Intrinsic Value_10Y_min---28.490--------
Intrinsic Value_1Y_max---0.978--------
Intrinsic Value_1Y_min---0.959--------
Intrinsic Value_3Y_max---4.796--------
Intrinsic Value_3Y_min---4.541--------
Intrinsic Value_5Y_max---10.853--------
Intrinsic Value_5Y_min---9.914--------
Market Cap1766652270.400+11%1577561816.8402820208207.410-44%3260760698.080-52%4335464061.272-64%6053674899.073-74%
Net Profit Margin---0.521-0.225-57%-0.134-74%-0.011-98%0.047-1204%
Operating Margin----0.0160%-0.0220%0.044-100%0.079-100%
Operating Ratio--2.1121.943+9%1.762+20%1.747+21%1.673+26%
Pb Ratio1.747+11%1.5602.549-39%2.733-43%5.363-71%11.684-87%
Pe Ratio-4.652-12%-4.154-28.869+595%-46.408+1017%120.351-103%112.514-104%
Price Per Share9.950+11%8.88515.884-44%18.365-52%24.069-63%21.287-58%
Price To Free Cash Flow Ratio-4.904-12%-4.379-16.503+277%-13.955+219%77.262-106%65.852-107%
Price To Total Gains Ratio-18.586-12%-16.597-122.566+638%-139.542+741%-108.562+554%61.846-127%
Quick Ratio--0.5810.564+3%1.001-42%0.853-32%0.889-35%
Return On Assets---0.047-0.020-57%-0.011-76%0.000-99%0.007-809%
Return On Equity---0.094-0.040-57%-0.021-77%0.000-33206%0.013-843%
Total Gains Per Share---0.535-0.229-57%-0.143-73%0.161-432%0.184-391%
Usd Book Value--1059915221.4001147112028.300-8%1251501992.475-15%988070097.105+7%768836894.700+38%
Usd Book Value Change Per Share---0.561-0.240-57%-0.149-73%0.169-432%0.193-391%
Usd Book Value Per Share--5.9706.461-8%7.049-15%5.530+8%4.169+43%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.560-0.252-55%-0.134-76%-0.035-94%-0.008-99%
Usd Free Cash Flow---94382257.200-64804493.775-31%-64732188.675-31%-18368848.680-81%-6661094.661-93%
Usd Free Cash Flow Per Share---0.532-0.365-31%-0.365-31%-0.104-80%-0.050-91%
Usd Free Cash Flow To Equity Per Share---1.234-0.459-63%-0.348-72%0.053-2447%0.130-1052%
Usd Market Cap1851274914.152+11%1653127027.8672955296180.545-44%3416951135.518-52%4543132789.807-64%6343645926.739-74%
Usd Price Per Share10.427+11%9.31116.645-44%19.245-52%25.222-63%22.307-58%
Usd Profit---99479242.800-44716774.725-55%-27062803.425-73%-6332250.120-94%456952.006-21870%
Usd Revenue--190846691.700206551569.000-8%209162935.800-9%171961961.850+11%140825354.216+36%
Usd Total Gains Per Share---0.561-0.240-57%-0.149-73%0.169-432%0.193-391%
 EOD+5 -3MRQTTM+6 -26YOY+3 -295Y+11 -2210Y+8 -25

3.3 Fundamental Score

Let's check the fundamental score of Evotec SE based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.652
Price to Book Ratio (EOD)Between0-11.747
Net Profit Margin (MRQ)Greater than0-0.521
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.581
Current Ratio (MRQ)Greater than11.834
Debt to Asset Ratio (MRQ)Less than10.494
Debt to Equity Ratio (MRQ)Less than10.976
Return on Equity (MRQ)Greater than0.15-0.094
Return on Assets (MRQ)Greater than0.05-0.047
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Evotec SE based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.947
Ma 20Greater thanMa 508.348
Ma 50Greater thanMa 1006.933
Ma 100Greater thanMa 2007.090
OpenGreater thanClose9.725
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Evotec SE

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health. It has collaboration agreements with SK bioscience, JingXin, Carrick Therapeutics, Sernova, Topas Therapeutics, Exscientia, CONBA Group, Centrexion, Sanofi/NIH, Kazia Therapeutics, Bristol Myers Squibb, Topas Therapeutics, Immunitas, Exscientia, and Bayer; and Inserm, the French National Institute of Health and Medical Research, Lille University Hospital, and Inserm Transfert to identify novel therapeutic targets and diagnostic and prognostic markers in obesity and metabolic diseases, as well as collaboration with CHDI Foundation, Inc.; and a strategic partnership with Dewpoint Therapeutics to advance its portfolio targeting biomolecular condensates as a novel domain for therapeutic intervention towards the clinic, as well as research collaboration with Pfizer for metabolic and infectious diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Fundamental data was last updated by Penke on 2024-11-10 07:47:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Evotec earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Evotec to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -52.1% means that €-0.52 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Evotec SE:

  • The MRQ is -52.1%. The company is making a huge loss. -2
  • The TTM is -22.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-52.1%TTM-22.5%-29.7%
TTM-22.5%YOY-13.4%-9.0%
TTM-22.5%5Y-1.1%-21.4%
5Y-1.1%10Y4.7%-5.8%
4.3.1.2. Return on Assets

Shows how efficient Evotec is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Evotec to the Drug Manufacturers - Specialty & Generic industry mean.
  • -4.7% Return on Assets means that Evotec generated €-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Evotec SE:

  • The MRQ is -4.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.7%TTM-2.0%-2.7%
TTM-2.0%YOY-1.1%-0.9%
TTM-2.0%5Y0.0%-2.0%
5Y0.0%10Y0.7%-0.7%
4.3.1.3. Return on Equity

Shows how efficient Evotec is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Evotec to the Drug Manufacturers - Specialty & Generic industry mean.
  • -9.4% Return on Equity means Evotec generated €-0.09 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Evotec SE:

  • The MRQ is -9.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.4%TTM-4.0%-5.4%
TTM-4.0%YOY-2.1%-1.9%
TTM-4.0%5Y0.0%-4.1%
5Y0.0%10Y1.3%-1.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Evotec SE.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Evotec is operating .

  • Measures how much profit Evotec makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Evotec to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Evotec SE:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1.6%+1.6%
TTM-1.6%YOY-2.2%+0.7%
TTM-1.6%5Y4.4%-5.9%
5Y4.4%10Y7.9%-3.5%
4.3.2.2. Operating Ratio

Measures how efficient Evotec is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 2.11 means that the operating costs are €2.11 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Evotec SE:

  • The MRQ is 2.112. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.943. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.112TTM1.943+0.169
TTM1.943YOY1.762+0.181
TTM1.9435Y1.747+0.196
5Y1.74710Y1.673+0.074
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Evotec SE.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Evotec is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.83 means the company has €1.83 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Evotec SE:

  • The MRQ is 1.834. The company is able to pay all its short-term debts. +1
  • The TTM is 1.952. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.834TTM1.952-0.118
TTM1.952YOY2.124-0.173
TTM1.9525Y2.514-0.563
5Y2.51410Y2.351+0.163
4.4.3.2. Quick Ratio

Measures if Evotec is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Evotec to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.58 means the company can pay off €0.58 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Evotec SE:

  • The MRQ is 0.581. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.564. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.581TTM0.564+0.017
TTM0.564YOY1.001-0.438
TTM0.5645Y0.853-0.289
5Y0.85310Y0.889-0.036
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Evotec SE.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Evotec assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Evotec to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.49 means that Evotec assets are financed with 49.4% credit (debt) and the remaining percentage (100% - 49.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Evotec SE:

  • The MRQ is 0.494. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.497. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.494TTM0.497-0.003
TTM0.497YOY0.474+0.024
TTM0.4975Y0.499-0.002
5Y0.49910Y0.480+0.019
4.5.4.2. Debt to Equity Ratio

Measures if Evotec is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Evotec to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 97.6% means that company has €0.98 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Evotec SE:

  • The MRQ is 0.976. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.990. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.976TTM0.990-0.014
TTM0.990YOY0.901+0.089
TTM0.9905Y1.028-0.038
5Y1.02810Y0.970+0.059
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Evotec generates.

  • Above 15 is considered overpriced but always compare Evotec to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -4.15 means the investor is paying €-4.15 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Evotec SE:

  • The EOD is -4.652. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.154. Based on the earnings, the company is expensive. -2
  • The TTM is -28.869. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.652MRQ-4.154-0.498
MRQ-4.154TTM-28.869+24.715
TTM-28.869YOY-46.408+17.539
TTM-28.8695Y120.351-149.221
5Y120.35110Y112.514+7.837
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Evotec SE:

  • The EOD is -4.904. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.379. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -16.503. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.904MRQ-4.379-0.525
MRQ-4.379TTM-16.503+12.124
TTM-16.503YOY-13.955-2.548
TTM-16.5035Y77.262-93.765
5Y77.26210Y65.852+11.411
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Evotec is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.56 means the investor is paying €1.56 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Evotec SE:

  • The EOD is 1.747. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.560. Based on the equity, the company is underpriced. +1
  • The TTM is 2.549. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.747MRQ1.560+0.187
MRQ1.560TTM2.549-0.990
TTM2.549YOY2.733-0.183
TTM2.5495Y5.363-2.813
5Y5.36310Y11.684-6.322
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets1,998,893
Total Liabilities987,427
Total Stockholder Equity1,011,466
 As reported
Total Liabilities 987,427
Total Stockholder Equity+ 1,011,466
Total Assets = 1,998,893

Assets

Total Assets1,998,893
Total Current Assets655,505
Long-term Assets1,343,388
Total Current Assets
Cash And Cash Equivalents 221,883
Short-term Investments 87,335
Net Receivables 120,250
Inventory 37,343
Other Current Assets 48,754
Total Current Assets  (as reported)655,505
Total Current Assets  (calculated)515,565
+/- 139,940
Long-term Assets
Property Plant Equipment 819,733
Long Term Investments 129,281
Long-term Assets  (as reported)1,343,388
Long-term Assets  (calculated)949,014
+/- 394,374

Liabilities & Shareholders' Equity

Total Current Liabilities357,479
Long-term Liabilities629,948
Total Stockholder Equity1,011,466
Total Current Liabilities
Accounts payable 86,942
Other Current Liabilities 27,076
Total Current Liabilities  (as reported)357,479
Total Current Liabilities  (calculated)114,018
+/- 243,461
Long-term Liabilities
Long-term Liabilities Other 22,957
Long-term Liabilities  (as reported)629,948
Long-term Liabilities  (calculated)22,957
+/- 606,991
Total Stockholder Equity
Total Stockholder Equity (as reported)1,011,466
Total Stockholder Equity (calculated)0
+/- 1,011,466
Other
Capital Stock177,553
Common Stock Shares Outstanding 177,553
Net Invested Capital 1,011,466
Net Working Capital 298,026



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
351,366
418,752
421,482
644,006
667,268
665,300
693,768
770,343
771,883
880,821
1,067,608
1,083,921
1,180,912
1,183,566
1,190,678
1,169,671
1,462,895
1,580,707
1,621,116
1,767,849
2,235,161
2,185,023
2,293,715
2,262,664
2,257,247
0
2,301,221
2,254,509
2,252,468
2,208,650
1,998,893
1,998,8932,208,6502,252,4682,254,5092,301,22102,257,2472,262,6642,293,7152,185,0232,235,1611,767,8491,621,1161,580,7071,462,8951,169,6711,190,6781,183,5661,180,9121,083,9211,067,608880,821771,883770,343693,768665,300667,268644,006421,482418,752351,366
   > Total Current Assets 
169,235
233,174
233,231
184,498
180,252
175,346
207,752
274,018
249,769
254,649
464,056
410,102
469,530
464,623
445,584
427,185
658,844
680,401
634,802
628,306
1,100,940
1,061,513
1,144,465
1,095,817
1,073,671
0
1,026,449
939,198
903,162
826,147
655,505
655,505826,147903,162939,1981,026,44901,073,6711,095,8171,144,4651,061,5131,100,940628,306634,802680,401658,844427,185445,584464,623469,530410,102464,056254,649249,769274,018207,752175,346180,252184,498233,231233,174169,235
       Cash And Cash Equivalents 
83,940
77,616
87,999
56,809
67,017
57,352
91,309
135,140
109,055
111,630
322,259
249,619
277,034
285,410
224,436
215,900
422,164
401,597
382,311
333,404
699,326
660,488
696,992
463,913
415,155
0
459,752
499,366
499,089
428,311
221,883
221,883428,311499,089499,366459,7520415,155463,913696,992660,488699,326333,404382,311401,597422,164215,900224,436285,410277,034249,619322,259111,630109,055135,14091,30957,35267,01756,80987,99977,61683,940
       Short-term Investments 
43,922
109,621
102,604
44,937
34,558
34,418
18,925
33,935
40,824
30,466
19,503
33,568
44,628
35,861
51,986
42,059
70,054
68,979
77,392
93,824
159,172
194,557
193,904
364,882
314,828
0
173,221
119,814
99,825
90,473
87,335
87,33590,47399,825119,814173,2210314,828364,882193,904194,557159,17293,82477,39268,97970,05442,05951,98635,86144,62833,56819,50330,46640,82433,93518,92534,41834,55844,937102,604109,62143,922
       Net Receivables 
29,828
31,934
29,285
52,089
59,372
57,539
71,691
74,050
81,411
48,817
51,604
51,823
117,844
104,630
128,007
129,137
122,221
154,670
116,179
136,615
176,754
134,019
149,836
187,997
168,653
0
291,301
219,371
98,396
115,819
120,250
120,250115,81998,396219,371291,3010168,653187,997149,836134,019176,754136,615116,179154,670122,221129,137128,007104,630117,84451,82351,60448,81781,41174,05071,69157,53959,37252,08929,28531,93429,828
       Inventory 
4,305
4,644
4,436
12,820
9,017
6,102
5,260
6,738
5,660
5,643
6,521
12,200
10,749
10,860
10,597
11,689
13,585
15,237
17,254
22,519
25,793
26,076
28,995
30,874
29,825
0
32,612
31,906
30,890
31,838
37,343
37,34331,83830,89031,90632,612029,82530,87428,99526,07625,79322,51917,25415,23713,58511,68910,59710,86010,74912,2006,5215,6435,6606,7385,2606,1029,01712,8204,4364,6444,305
       Other Current Assets 
2,679
0
0
0
1,688
0
0
0
7,381
29,974
0
0
10,109
27,862
30,558
28,400
21,146
10,020
10,368
9,653
20,949
229
3,017
5,128
51,672
0
12,127
5,812
15,108
61,651
48,754
48,75461,65115,1085,81212,127051,6725,1283,01722920,9499,65310,36810,02021,14628,40030,55827,86210,1090029,9747,3810001,6880002,679
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
626,172
603,552
673,819
711,382
718,943
745,094
742,486
804,051
900,306
986,314
1,139,543
1,134,221
1,123,510
1,149,250
1,166,847
1,183,576
0
1,274,772
1,315,311
1,349,306
1,382,503
1,343,388
1,343,3881,382,5031,349,3061,315,3111,274,77201,183,5761,166,8471,149,2501,123,5101,134,2211,139,543986,314900,306804,051742,486745,094718,943711,382673,819603,552626,172000000000
       Property Plant Equipment 
43,223
43,658
43,924
74,596
73,425
76,642
80,191
88,862
89,310
190,078
192,058
224,513
237,999
245,698
264,256
270,291
335,723
374,930
449,474
472,825
484,597
521,357
559,531
600,499
650,201
0
721,136
763,899
806,562
826,896
819,733
819,733826,896806,562763,899721,1360650,201600,499559,531521,357484,597472,825449,474374,930335,723270,291264,256245,698237,999224,513192,058190,07889,31088,86280,19176,64273,42574,59643,92443,65843,223
       Goodwill 
93,227
93,446
83,717
300,790
220,178
220,880
220,413
221,491
220,791
225,203
219,142
257,304
255,919
252,916
249,188
247,475
247,370
254,041
252,961
253,709
257,569
257,649
259,003
278,417
274,819
0
277,490
0
275,635
0
0
00275,6350277,4900274,819278,417259,003257,649257,569253,709252,961254,041247,370247,475249,188252,916255,919257,304219,142225,203220,791221,491220,413220,880220,178300,79083,71793,44693,227
       Long Term Investments 
3,968
6,578
5,965
22,503
22,141
23,981
23,411
22,838
28,990
28,598
27,921
30,381
0
0
0
0
0
0
175,425
303,841
287,009
236,624
217,159
189,245
150,332
0
160,842
151,620
142,094
135,626
129,281
129,281135,626142,094151,620160,8420150,332189,245217,159236,624287,009303,841175,42500000030,38127,92128,59828,99022,83823,41123,98122,14122,5035,9656,5783,968
       Intangible Assets 
22,652
21,941
29,985
27,534
136,270
132,165
125,327
122,496
124,198
121,021
107,170
105,334
116,994
113,228
109,132
105,800
98,036
95,693
35,814
33,227
30,851
29,157
26,985
25,736
23,819
0
15,122
0
15,454
0
0
0015,454015,122023,81925,73626,98529,15730,85133,22735,81495,69398,036105,800109,132113,228116,994105,334107,170121,021124,198122,496125,327132,165136,27027,53429,98521,94122,652
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
931
895
907
940
905
881
879
892
859
852
849
870
864
851
0
3,785
0
0
0
838
852
0
08528380003,7850851864870849852859892879881905940907895931000000000
> Total Liabilities 
137,430
105,418
107,270
325,723
335,521
326,015
340,706
380,088
347,003
432,563
628,476
621,293
703,883
694,094
714,599
696,899
740,049
787,661
768,542
775,170
857,476
875,162
1,018,176
1,034,138
1,070,063
0
1,126,934
1,113,690
1,132,560
1,102,135
987,427
987,4271,102,1351,132,5601,113,6901,126,93401,070,0631,034,1381,018,176875,162857,476775,170768,542787,661740,049696,899714,599694,094703,883621,293628,476432,563347,003380,088340,706326,015335,521325,723107,270105,418137,430
   > Total Current Liabilities 
73,390
44,722
46,860
268,328
245,775
241,747
224,368
235,672
196,275
187,147
143,318
133,839
178,955
185,038
181,487
194,875
208,459
239,606
246,947
253,778
324,516
339,620
320,556
340,802
337,706
0
488,107
434,045
464,573
443,047
357,479
357,479443,047464,573434,045488,1070337,706340,802320,556339,620324,516253,778246,947239,606208,459194,875181,487185,038178,955133,839143,318187,147196,275235,672224,368241,747245,775268,32846,86044,72273,390
       Short-term Debt 
28,827
8,326
7,931
165,150
12,671
161,472
131,464
98,167
2,069
54,818
16,651
1,798
6,343
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000006,3431,79816,65154,8182,06998,167131,464161,47212,671165,1507,9318,32628,827
       Short Long Term Debt 
28,827
8,326
7,931
165,150
12,671
161,472
131,464
98,167
2,069
54,818
16,651
1,798
6,343
6,423
6,101
15,696
15,392
15,264
50,000
35,000
36,136
36,145
0
223
1,556
0
0
0
129,971
0
0
00129,9710001,556223036,14536,13635,00050,00015,26415,39215,6966,1016,4236,3431,79816,65154,8182,06998,167131,464161,47212,671165,1507,9318,32628,827
       Accounts payable 
11,997
10,587
12,360
25,142
26,078
27,986
23,617
24,226
31,137
32,583
26,637
27,965
31,319
41,792
37,473
44,142
42,549
54,880
51,363
56,720
72,598
74,739
80,893
83,965
97,277
0
106,038
96,774
134,319
99,145
86,942
86,94299,145134,31996,774106,038097,27783,96580,89374,73972,59856,72051,36354,88042,54944,14237,47341,79231,31927,96526,63732,58331,13724,22623,61727,98626,07825,14212,36010,58711,997
       Other Current Liabilities 
25,977
32,688
33,099
77,265
32,268
28,874
68,584
112,051
70,424
11,931
7,950
11,757
96,003
121,667
120,360
121,807
99,899
154,581
131,675
147,702
165,848
214,240
225,281
242,729
174,828
0
230,431
192,984
15,361
25,285
27,076
27,07625,28515,361192,984230,4310174,828242,729225,281214,240165,848147,702131,675154,58199,899121,807120,360121,66796,00311,7577,95011,93170,424112,05168,58428,87432,26877,26533,09932,68825,977
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
245,416
485,158
487,454
524,928
509,056
533,112
502,024
531,590
548,055
521,595
521,392
532,960
535,542
697,620
693,336
732,357
0
638,827
679,645
667,987
659,088
629,948
629,948659,088667,987679,645638,8270732,357693,336697,620535,542532,960521,392521,595548,055531,590502,024533,112509,056524,928487,454485,158245,416000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
104,505
104,837
120,447
131,870
128,539
142,848
107,985
145,554
148,613
144,707
147,689
150,437
156,306
157,240
165,093
176,823
0
0
0
189,140
0
0
00189,140000176,823165,093157,240156,306150,437147,689144,707148,613145,554107,985142,848128,539131,870120,447104,837104,505000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
205
205
467
467
466
464
977
0
383,402
851
1,387
2,239
22,957
22,9572,2391,387851383,4020977464466467467205205000000000000000000
> Total Stockholder Equity
213,035
312,261
313,202
317,275
330,755
338,295
352,072
389,378
424,004
447,387
438,261
461,789
477,029
489,472
476,079
472,772
722,846
793,046
852,574
992,679
1,377,685
1,309,861
1,275,539
1,228,526
1,187,184
0
1,174,287
1,140,819
1,119,908
1,106,515
1,011,466
1,011,4661,106,5151,119,9081,140,8191,174,28701,187,1841,228,5261,275,5391,309,8611,377,685992,679852,574793,046722,846472,772476,079489,472477,029461,789438,261447,387424,004389,378352,072338,295330,755317,275313,202312,261213,035
   Common Stock
133,052
146,569
146,670
147,494
147,533
147,547
147,547
147,584
149,063
149,765
149,896
150,530
150,903
151,242
151,450
151,897
163,915
164,561
164,608
165,111
176,608
176,953
176,953
176,953
0
0
177,186
177,186
0
0
0
000177,186177,18600176,953176,953176,953176,608165,111164,608164,561163,915151,897151,450151,242150,903150,530149,896149,765149,063147,584147,547147,547147,533147,494146,670146,569133,052
   Retained Earnings Total Equity0000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000
   Other Stockholders Equity 
-25,152
-24,495
-27,595
-28,309
-28,903
753,097
-28,071
-27,398
755,954
-20,671
-27,386
-25,487
-19,562
-20,716
-30,912
-34,433
-37,522
-22,395
-25,013
-21,625
-12,638
-9,912
-19,359
-21,348
0
0
-27,052
0
0
0
0
0000-27,05200-21,348-19,359-9,912-12,638-21,625-25,013-22,395-37,522-34,433-30,912-20,716-19,562-25,487-27,386-20,671755,954-27,398-28,071753,097-28,903-28,309-27,595-24,495-25,152



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue781,426
Cost of Revenue-606,375
Gross Profit175,051175,051
 
Operating Income (+$)
Gross Profit175,051
Operating Expense-823,923
Operating Income-42,497-648,872
 
Operating Expense (+$)
Research Development57,519
Selling General Administrative169,610
Selling And Marketing Expenses0
Operating Expense823,923227,129
 
Net Interest Income (+$)
Interest Income9,263
Interest Expense-11,739
Other Finance Cost-0
Net Interest Income-2,476
 
Pretax Income (+$)
Operating Income-42,497
Net Interest Income-2,476
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-80,593-6,877
EBIT - interestExpense = -11,739
-83,913
-72,174
Interest Expense11,739
Earnings Before Interest and Taxes (EBIT)0-68,854
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-80,593
Tax Provision-3,320
Net Income From Continuing Ops-83,913-83,913
Net Income-83,913
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-35,6202,476
 

Technical Analysis of Evotec
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Evotec. The general trend of Evotec is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Evotec's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Evotec SE.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 10.69 < 12.63 < 12.88.

The bearish price targets are: 7.005 > 6.96 > 6.62.

Tweet this
Evotec SE Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Evotec SE. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Evotec SE Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Evotec SE. The current macd is 0.94771224.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Evotec price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Evotec. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Evotec price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Evotec SE Daily Moving Average Convergence/Divergence (MACD) ChartEvotec SE Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Evotec SE. The current adx is 41.12.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Evotec shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Evotec SE Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Evotec SE. The current sar is 9.285.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Evotec SE Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Evotec SE. The current rsi is 65.95. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Evotec SE Daily Relative Strength Index (RSI) ChartEvotec SE Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Evotec SE. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Evotec price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Evotec SE Daily Stochastic Oscillator ChartEvotec SE Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Evotec SE. The current cci is 98.45.

Evotec SE Daily Commodity Channel Index (CCI) ChartEvotec SE Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Evotec SE. The current cmo is 31.82.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Evotec SE Daily Chande Momentum Oscillator (CMO) ChartEvotec SE Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Evotec SE. The current willr is -20.26666667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Evotec is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Evotec SE Daily Williams %R ChartEvotec SE Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Evotec SE.

Evotec SE Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Evotec SE. The current atr is 0.65968511.

Evotec SE Daily Average True Range (ATR) ChartEvotec SE Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Evotec SE. The current obv is -197,353.

Evotec SE Daily On-Balance Volume (OBV) ChartEvotec SE Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Evotec SE. The current mfi is 68.23.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Evotec SE Daily Money Flow Index (MFI) ChartEvotec SE Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Evotec SE.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-11 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-12 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-16 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-24 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-25 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-02 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-06 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-07 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-23 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-27 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-30 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-13 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-16 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-20 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-23 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-25 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-26 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-27 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-30 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-01 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-10 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-14 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-16 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-23 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-28 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-31 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-11-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-05 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-07 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-12 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-19 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Evotec SE Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Evotec SE based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.947
Ma 20Greater thanMa 508.348
Ma 50Greater thanMa 1006.933
Ma 100Greater thanMa 2007.090
OpenGreater thanClose9.725
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Evotec with someone you think should read this too:
  • Are you bullish or bearish on Evotec? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Evotec? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Evotec SE

I send you an email if I find something interesting about Evotec SE.


Comments

How you think about this?

Leave a comment

Stay informed about Evotec SE.

Receive notifications about Evotec SE in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.